AEON Biopharma, Inc. Basic Shares Outstanding (Weighted Average)
AEON Biopharma, Inc. (AEON) reported Basic Shares Outstanding (Weighted Average) of 50.53 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- AEON Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 50.53M shares, a 355.61% increase year-over-year.
- AEON Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 40.61M shares, a 919.21% increase year-over-year.
- AEON Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 12.89M shares, a 2225.50% increase year-over-year.
- AEON Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 11.63M shares, a 2018.62% increase year-over-year.
- AEON Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 9.92M shares, a 1736.11% increase from fiscal 2024.
- AEON Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 540.36K shares.
- AEON Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 138.85M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 1 month | Weighted Average Number of Shares Outstanding, Basic 2 month | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 5 month | Weighted Average Number of Shares Outstanding, Basic 5 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 7 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 50.53M shares 10-Q · filed 2026-08-12 | 45.60M shares 10-Q · filed 2026-08-12 | 34.68M shares derived: average of 3 quarters · filed 2026-08-12 | 28.92M shares derived: average of 4 quarters · filed 2026-08-12 | ||||||||
| 2026-03-31 | 40.61M shares 10-Q · filed 2026-05-14 | 26.75M shares derived: average of 2 quarters · filed 2026-05-14 | 21.71M shares derived: average of 3 quarters · filed 2026-05-14 | 19.06M shares derived: average of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-12-31 | 12.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 12.26M shares derived: average of 2 quarters · filed 2026-03-30 | 11.87M shares derived: average of 3 quarters · filed 2026-08-12 | 9.92M shares 10-K · filed 2026-03-30 | ||||||||
| 2025-09-30 | 11.63M shares 10-Q · filed 2025-11-14 | 11.36M shares derived: average of 2 quarters · filed 2026-08-12 | 8.93M shares 10-Q · filed 2025-11-14 | 6.82M shares derived: average of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-06-30 | 11.09M shares 10-Q · filed 2026-08-12 | 7.56M shares 10-Q · filed 2026-08-12 | 5.21M shares derived: average of 3 quarters · filed 2026-08-12 | 4.04M shares derived: average of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-03-31 | 3.98M shares 10-Q · filed 2026-05-14 | 2.27M shares derived: average of 2 quarters · filed 2026-05-14 | 1.70M shares derived: average of 3 quarters · filed 2026-05-14 | 1.41M shares derived: average of 4 quarters · filed 2026-05-14 | ||||||||
| 2024-12-31 | 554.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 551.77K shares derived: average of 2 quarters · filed 2026-03-30 | 547.79K shares derived: average of 3 quarters · filed 2026-03-30 | 540.36K shares 10-K · filed 2026-03-30 | ||||||||
| 2024-09-30 | 549.17K shares 10-Q · filed 2025-11-14 | 39.52M shares 10-Q · filed 2024-11-13 | 544.51K shares derived: average of 2 quarters · filed 2025-11-14 | 535.69K shares 10-Q · filed 2025-11-14 | 38.55M shares 10-Q · filed 2024-11-13 | |||||||
| 2024-06-30 | 539.84K shares 10-Q · filed 2025-08-12 | 38.84M shares 10-Q · filed 2024-08-12 | 528.88K shares 10-Q · filed 2025-08-12 | 38.06M shares 10-Q · filed 2024-08-12 | ||||||||
| 2024-03-31 | 517.91K shares 10-Q · filed 2025-05-14 | 37.27M shares 10-Q · filed 2024-05-14 | ||||||||||
| 2023-12-31 | 516.40K shares 10-K · filed 2025-03-24 | 37.16M shares 10-K · filed 2024-03-29 | ||||||||||
| 2023-09-30 | 37.16M shares 10-Q/A · filed 2024-03-29 | |||||||||||
| 2023-07-21 | 138.85M shares 10-Q · filed 2024-11-13 | 138.85M shares 10-K · filed 2025-03-24 | ||||||||||
| 2023-06-30 | 138.83M shares 10-Q · filed 2024-08-12 | 138.83M shares 10-Q · filed 2024-08-12 | 138.83M shares derived: average of 3 quarters · filed 2024-08-12 | 138.84M shares derived: average of 4 quarters · filed 2024-08-12 | ||||||||
| 2023-03-31 | 138.83M shares 10-Q · filed 2024-05-14 | 138.84M shares derived: average of 2 quarters · filed 2024-05-14 | 138.84M shares derived: average of 3 quarters · filed 2024-05-14 | |||||||||
| 2022-12-31 | 138.85M shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-05-14 | 138.85M shares derived: average of 2 quarters · filed 2024-05-14 | 138.85M shares 10-K/A · filed 2024-05-14 | |||||||||
| 2022-09-30 | 138.85M shares 10-Q/A · filed 2024-03-29 | 138.85M shares 10-Q/A · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |